P. Lio, Yestle Kim, S. Balu, A. Guana, D. Bates, D. Mackie, H. Costantino, A. López, J. Soung
{"title":"接受曲洛单抗治疗的中度至重度特应性皮炎成年患者的真实基线特征和早期患者报告的结果","authors":"P. Lio, Yestle Kim, S. Balu, A. Guana, D. Bates, D. Mackie, H. Costantino, A. López, J. Soung","doi":"10.25251/skin.7.supp.145","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74803,"journal":{"name":"Skin (Milwood, N.Y.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real World Baseline Characteristics and Early Patient Reported Outcomes in Adult Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab\",\"authors\":\"P. Lio, Yestle Kim, S. Balu, A. Guana, D. Bates, D. Mackie, H. Costantino, A. López, J. Soung\",\"doi\":\"10.25251/skin.7.supp.145\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74803,\"journal\":{\"name\":\"Skin (Milwood, N.Y.)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Skin (Milwood, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25251/skin.7.supp.145\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin (Milwood, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25251/skin.7.supp.145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Real World Baseline Characteristics and Early Patient Reported Outcomes in Adult Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab